StockData
Cellyan Biotechnology Co., Ltd logo

Cellyan Biotechnology Co., Ltd (HKPD) stock

HKPDNasdaqWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends March 31
Financials through fiscal 2026, year ended Mar 31, 2026Last filing: 20-F on Aug 7, 2026Score 3/30
$1.33−0.19 (-12.76%)

Close on Nov 18, 2026Market cap $21.75MP/E –Yield –

Cellyan Biotechnology pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Cellyan Biotechnology's pe ratio was 130.0× on May 30, 2025.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2025May 30, 2025130.0×–

More Cellyan Biotechnology figures

See a number that looks wrong?